Oct 25, 2024 Press Releases BioSTL Names Dr. James McCarter to Lead its Investment Arm, BioGenerator Ventures
Oct 13, 2023 In the News BioGenerator Company Immunophotonics Announces 1st Patient Dosed in the United States under its IND Application
Oct 12, 2023 Press Releases BioGenerator Company SentiAR Announces Second FDA Clearance for CommandEP™ Interface
Sep 27, 2023 BioGenerator Company Omniose Lands $3.0 Million to Develop Vaccines against Group B Streptococcus
Sep 19, 2023 In the News BioGenerator Company Aclaris Announces Positive Phase 1 Data for ITK/JAK3 inhibitor
Aug 26, 2023 In the News Managing Director of BioGenerator Ventures, Matt Helms, Builds Unique Ag-Food Business
Aug 15, 2023 In the News BioGenerator Company Wugen Begins Phase 1 Clinical Trial of Allogeneic Memory Natural Killer (NK) Cell Therapy
